Cargando…

Therapeutic mechanism of baicalein in peritoneal dialysis-associated peritoneal fibrosis based on network pharmacology and experimental validation

Baicalein (5,6,7-trihydroxyflavone) is a traditional Chinese medicine with multiple pharmacological and biological activities including anti-inflammatory and anti-fibrotic effects. However, whether baicalein has a therapeutic impact on peritoneal fibrosis has not been reported yet. In the present st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Xiaohui, Wu, Kefei, Jiang, Simin, Li, Yi, Wang, Yating, Li, Hongyu, Li, Guanglan, Liu, Qinghua, Zhou, Yi, Chen, Wei, Mao, Haiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229821/ https://www.ncbi.nlm.nih.gov/pubmed/37266145 http://dx.doi.org/10.3389/fphar.2023.1153503

Ejemplares similares

Systemic Immune-Inflammation Index Was Significantly Associated with All-Cause and Cardiovascular-Specific Mortalities in Patients Receiving Peritoneal Dialysis
por: Li, Guanglan, et al.
Publicado: (2023)

Inhibition of calpain9 attenuates peritoneal dialysis-related peritoneal fibrosis
por: Li, Fang, et al.
Publicado: (2022)

Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation
por: Lu, Jing, et al.
Publicado: (2023)

Blockade of prostaglandin E2 receptor 4 ameliorates peritoneal dialysis-associated peritoneal fibrosis
por: Luo, Qimei, et al.
Publicado: (2022)

The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients
por: Ye, Hongjian, et al.
Publicado: (2017)

The Potential Role of HMGB1 Release in Peritoneal Dialysis-Related Peritonitis
por: Cao, Shirong, et al.
Publicado: (2013)

Pharmacokinetics of Intraperitoneal Vancomycin and Amikacin in Automated Peritoneal Dialysis Patients With Peritonitis
por: Falbo dos Reis, Pâmela, et al.
Publicado: (2021)

The Role of Peritoneal Alternatively Activated Macrophages in the Process of Peritoneal Fibrosis Related to Peritoneal Dialysis
por: Wang, Jie, et al.
Publicado: (2013)

The Gut-Peritoneum Axis in Peritoneal Dialysis and Peritoneal Fibrosis
por: Stepanova, Natalia
Publicado: (2023)

Elabela Attenuates the TGF-β1-Induced Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells in Patients Receiving Peritoneal Dialysis
por: Xie, Shunyun, et al.
Publicado: (2022)

Blockade of Autophagy Prevents the Development and Progression of Peritoneal Fibrosis
por: Shi, Yingfeng, et al.
Publicado: (2021)

The Role of Cathepsin B in Peritoneal Fibrosis due to Peritoneal Dialysis
por: Sung, Su Ah, et al.
Publicado: (2019)

Fibrosis of Peritoneal Membrane as Target of New Therapies in Peritoneal Dialysis
por: Masola, Valentina, et al.
Publicado: (2022)

A review of research progress on mechanisms of peritoneal fibrosis related to peritoneal dialysis
por: Li, Jin’e, et al.
Publicado: (2023)

High Peritoneal Transport Status Was Not Associated with Mortality in Peritoneal Dialysis Patients with Diabetes
por: Huang, Naya, et al.
Publicado: (2014)

Dipeptidyl peptidase 4 promotes peritoneal fibrosis and its inhibitions prevent failure of peritoneal dialysis
por: Li, Yi-Chen, et al.
Publicado: (2021)

Steviol glycosides as an alternative osmotic agent for peritoneal dialysis fluid
por: Kopytina, Valeria, et al.
Publicado: (2022)

The calcium concentration of peritoneal dialysis solution modifies levels of key mediators of peritoneal fibrosis
por: Miao, Chusheng, et al.
Publicado: (2020)

Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling
por: Huang, Qian, et al.
Publicado: (2022)

MiR-200a ameliorates peritoneal fibrosis and functional deterioration in a rat model of peritoneal dialysis
por: Wei, Xin, et al.
Publicado: (2019)

Roles of peritoneal clearance and residual kidney removal in control of uric acid in patients on peritoneal dialysis
por: Xiao, Xi, et al.
Publicado: (2020)

Effect of Mean Platelet Volume to Platelet Count Ratio on Mortality in Peritoneal Dialysis
por: Chen, Jiasi, et al.
Publicado: (2022)

Interaction effect between fasting plasma glucose and lipid profiles on mortality of peritoneal dialysis patients
por: Xu, Yiping, et al.
Publicado: (2022)

Experimental models in peritoneal dialysis (Review)
por: Yang, Bo, et al.
Publicado: (2021)

New Developments in Peritoneal Fibroblast Biology: Implications for Inflammation and Fibrosis in Peritoneal Dialysis
por: Witowski, Janusz, et al.
Publicado: (2015)

Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
por: Alvarez Nadal, Marta, et al.
Publicado: (2020)

Baicalein Alleviates Osteoarthritis Progression in Mice by Protecting Subchondral Bone and Suppressing Chondrocyte Apoptosis Based on Network Pharmacology
por: Yi, Nanxing, et al.
Publicado: (2022)

Serum Phosphorus and Albumin in Patients Undergoing Peritoneal Dialysis: Interaction and Association With Mortality
por: Huang, Naya, et al.
Publicado: (2021)

Aberrant Wnt/Beta-Catenin Pathway Activation in Dialysate-Induced Peritoneal Fibrosis
por: Guo, Yuanyuan, et al.
Publicado: (2017)

Baseline Peritoneal Membrane Transport Characteristics Are Associated with Peritonitis Risk in Incident Peritoneal Dialysis Patients
por: Chou, Yi-Hsin, et al.
Publicado: (2022)

Serum Hepcidin-25 and Risk of Mortality in Patients on Peritoneal Dialysis
por: Zhong, Zhong, et al.
Publicado: (2021)

Construction and validation of a predictive model for the risk of peritoneal dialysis-associated peritonitis after peritoneal dialysis catheterization
por: Dai, Rong, et al.
Publicado: (2023)

Peritoneal Dialysis Complicated by Sclerosing Peritonitis
por: Jiang, Zhifeng, et al.
Publicado: (2022)

Peritoneal Dialysis
por: Pyper, R. A.
Publicado: (1948)

Peritoneal Dialysis
por: Taskapan, Hulya, et al.
Publicado: (2011)

Pathophysiology of the Peritoneal Membrane during Peritoneal Dialysis: The Role of Hyaluronan
por: Yung, Susan, et al.
Publicado: (2011)

Crucial Role of NLRP3 Inflammasome in the Development of Peritoneal Dialysis-related Peritoneal Fibrosis
por: Hishida, Erika, et al.
Publicado: (2019)

Periostin-Binding DNA Aptamer Treatment Ameliorates Peritoneal Dialysis-Induced Peritoneal Fibrosis
por: Nam, Bo Young, et al.
Publicado: (2017)

Current Insights into Cellular Determinants of Peritoneal Fibrosis in Peritoneal Dialysis: A Narrative Review
por: Suryantoro, Satriyo Dwi, et al.
Publicado: (2023)

Newer antibiotics for the treatment of peritoneal dialysis-related peritonitis
por: Ma, Terry King-Wing, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_upuqn2cdbi8guv7nkp0eo74kjv